Artificial Skin Market - Growth, Trends, and Forecasts (2020-2025)

The Artificial Skin market is segmented by Product type (Permanent, Temporary and Composite), Replacement Area, Material, Application, End User and Geography

Artificial Skin Market Snapshot

Artificial Skin Market Summary
Study Period: 2017-2025
Base Year: 2019
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Artificial Skin market studied is expected to grow with an anticipated CAGR of 5.6%, during the forecast period. The major drivers propelling the growth of the artificial skin market are the increasing prevalence of acute and chronic wounds and high demand for the skin grafts. The increasing advancements in the healthcare based technology such as tissue engineering technology and biotechnology has been the major driving force for the artificial skin market.

An increase in the awareness of various skin treatment procedures has lead to the rising demand for artificial skin. Artificial skin lacks immunogenic cells like dendritic cells, and hence auto rejection is not observed. The increase in the number of road accidents, burn and trauma related incidents has lead to a significant growth of the artificial skin market. According to WHO, Burns are the fourth most common type of trauma worldwide and nearly 96% of the fatal fire-related burns occur in middle and low-income countries. An estimated 265000 deaths across globe occur annually due to fire accidents alone. Considering the mentioned facts and key drivers, the artificial skin market is anticipated to propel over the forecast period.

Scope of the Report

Artificial Skin is a synthetic substitute for human skin that can induce regeneration of skin, thereby significantly impacting the treatment of severe burns and injuries. Skin is the largest organ in the human body and comprises of two layers namely, epidermis and dermis. Severe burns and wounds make the body vulnerable to infections and impairs the healing process. Artificial skin helps to overcome this obstacle and quickens the healing of wounds and burns. Artificial skin does not contain any immunogenic cells, hence not rejected by the body.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Chronic wounds segment holds a substantial share in the market and is expected to increase over the forecast period

Chronic wounds include diabetic foot ulcers, venous leg ulcers and pressure ulcers. With the increase in the global geriatric population, diabetes and obesity, the prevalence of chronic wounds has been significantly increasing. The chronic wounds are affecting 5.7 million patients and costing approximately USD 20 billion annually in the United States. According to the International Diabetes Federation (IDF), approximately 463 million adults are living with diabetes and expected to rise to 700 million by 2045 and has lead to 4.5 million deaths in 2019. People with diabetes are at an increased risk of developing chronic wounds and infections. Diabetic foot and lower limb complications affect nearly 40 to 60 million people with diabetes globally. Hence, the prevalence of chronic wounds is expected to play a key role in the growth of the artificial skin market over the forecast period.

Artificial Skin market_ Segmentation Graph

North America has a dominant share in Artificial Skin market and is anticipated to grow tremendously over the forecast period

In the United States, 3% of the population above 65 years of age are with chronic wounds. The US government estimates that the elderly population will reach 55 million by 2020, which is proportionate to the increasing chronic wound incidents. As per the Wound Healing Society (WHS), the cost of wound care is expected as USD 3.5 billion in the United States in 2019. The number of road accidents in the United States were 12 million in 2018. As per the National Safety Council, about 4.4 million were severely injured in 2018, which required major medical attention including skin treatments. As per the mentioned statistics and increasing geriatric population, diabetes and obesity related complication, North America is expected to propel in the artificial skin market over the forecast period.

Artificial Skin Market_ Geography trend.png

Competitive Landscape

The Artificial Skin market is highly competitive and consists of significant major players, that dominate the market. Many small and medium-sized enterprises (SMEs) are also setting foot into the artificial skin market, thereby leading to an impactable growth over the forecast period. The major players in the Artificial Skin market are Integra Lifesciences Corporation, Smith & Nephew Plc, Molnlycke Health Care AB, Medtronic, 3M, Baxter International, MiMedX, Avita Medical, Mylan, Johnson and Johnson Services, Solsys Medical Inc., Paul Hartmann AG, Coloplast A/C and Convotec group Plc. The major players are evolving various strategies such as investment in Research and Development, collaborations and acquisitions. One such example is the acquisition of Acelity Inc. and its KCI subsidiaries, which is a global medical technology company focused on advanced wound management by 3M in Oct 2019.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Advancement in Healthcare Based Technology

      2. 4.2.2 Elevated Need for Skin Grafts

      3. 4.2.3 High Incidence of Acute and Chronic wounds

      4. 4.2.4 Increasing Awareness on Various Skin Treatments

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Treatment and Lack of Reimbursements

      2. 4.3.2 Stringent Regulatory Norms

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Permanent

      2. 5.1.2 Temporary

      3. 5.1.3 Composite

    2. 5.2 By Replacement area

      1. 5.2.1 Dermal

      2. 5.2.2 Epidermal

      3. 5.2.3 Composed

    3. 5.3 By Material

      1. 5.3.1 Natural

      2. 5.3.2 Synthetic

      3. 5.3.3 Both

    4. 5.4 By Application

      1. 5.4.1 Acute wounds

      2. 5.4.2 Chronic wounds

      3. 5.4.3 Others

    5. 5.5 By End User

      1. 5.5.1 Hospitals

      2. 5.5.2 Burn care Centers

      3. 5.5.3 Others

    6. 5.6 Geography

      1. 5.6.1 North America

        1. 5.6.1.1 United States

        2. 5.6.1.2 Canada

        3. 5.6.1.3 Mexico

      2. 5.6.2 Europe

        1. 5.6.2.1 Germany

        2. 5.6.2.2 United Kingdom

        3. 5.6.2.3 France

        4. 5.6.2.4 Italy

        5. 5.6.2.5 Spain

        6. 5.6.2.6 Rest of Europe

      3. 5.6.3 Asia Pacific

        1. 5.6.3.1 China

        2. 5.6.3.2 Japan

        3. 5.6.3.3 India

        4. 5.6.3.4 Australia

        5. 5.6.3.5 South Korea

        6. 5.6.3.6 Rest of Asia-Pacific

      4. 5.6.4 Middle East and Africa

        1. 5.6.4.1 GCC

        2. 5.6.4.2 South Africa

        3. 5.6.4.3 Rest of Middle East and Africa

      5. 5.6.5 South America

        1. 5.6.5.1 Brazil

        2. 5.6.5.2 Argentina

        3. 5.6.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Baxter International Inc

      2. 6.1.2 Convatec Group Plc

      3. 6.1.3 3M Company

      4. 6.1.4 Smith and Nephew

      5. 6.1.5 Molnlycke Health Care AB

      6. 6.1.6 Integra Lifesciences Corporation

      7. 6.1.7 Medtronic

      8. 6.1.8 Paul hartmann AG

      9. 6.1.9 Solsys Medical, LLC.

      10. 6.1.10 MiMedX

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Artificial Skin Market market is studied from 2017 - 2025.

The Artificial Skin Market is growing at a CAGR of 5.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2019.

Integra Lifesciences Corporation , Smith & Nephew Plc, Medtronic, Molnycke Health Care AB , Baxter International Inc. are the major companies operating in Artificial Skin Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!